Literature DB >> 16284955

Tubal sterilization in relation to breast cancer risk.

A Heather Eliassen1, Graham A Colditz, Bernard Rosner, Susan E Hankinson.   

Abstract

Tubal sterilization methods may damage surrounding tissue, potentially disrupting the ovarian blood supply and hormonal functioning, and may decrease breast cancer risk. We examined this hypothesis, within the Nurses' Health Study, among 77,511 women, aged 30-55 years and free of cancer at the start of follow-up in 1976. We documented 4,176 cases of invasive breast cancer from 1976 to 2000. Cox proportional hazards models, adjusting for multiple breast cancer risk factors, provided rate ratios (RR) and 95% confidence intervals (CI). Overall, tubal sterilization was not associated with breast cancer risk (RR=0.95, 95% CI=0.88-1.03). However, tubal sterilizations performed from 1970 to 1974 were inversely associated with risk (RR=0.84, 95% CI=0.73-0.97), while procedures performed in other years were not associated with risk. Among women with procedures performed in 1970-1974, those who were >or=35 years old at the time of sterilization were at the lowest risk (RR=0.81, 95% CI=0.66-0.98), while younger women had a suggested decreased risk (RR=0.87, 95% CI=0.72-1.06). Overall, tubal sterilization was not associated with breast cancer risk. However, a modest inverse association was observed at a time when the potentially destructive unipolar electrocautery method was commonly used, providing some support for an association between lower lifetime exposure to hormones and a decreased risk of breast cancer. Copyright (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16284955     DOI: 10.1002/ijc.21582

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  The association of plasma androgen levels with breast, ovarian and endometrial cancer risk factors among postmenopausal women.

Authors:  Kim N Danforth; A Heather Eliassen; Shelley S Tworoger; Stacey A Missmer; Robert L Barbieri; Bernard A Rosner; Graham A Colditz; Susan E Hankinson
Journal:  Int J Cancer       Date:  2010-01-01       Impact factor: 7.396

2.  Invited commentary: reproductive organ surgeries and breast cancer risk--apples, oranges, or fruit cocktail?

Authors:  David J Press; Leslie Bernstein
Journal:  Am J Epidemiol       Date:  2013-02-14       Impact factor: 4.897

3.  Breast cancer risk and ovariectomy, hysterectomy, and tubal sterilization in the women's contraceptive and reproductive experiences study.

Authors:  David J Press; Jane Sullivan-Halley; Giske Ursin; Dennis Deapen; Jill A McDonald; Brian L Strom; Sandra A Norman; Michael S Simon; Polly A Marchbanks; Suzanne G Folger; Jonathan M Liff; Ronald T Burkman; Kathleen E Malone; Linda K Weiss; Robert Spirtas; Leslie Bernstein
Journal:  Am J Epidemiol       Date:  2010-11-25       Impact factor: 4.897

4.  A systematic review and meta-analysis on tubal ligation and breast cancer risk.

Authors:  Nazila Najdi; Arezoo Esmailzadeh; Maryam Shokrpour; Somayeh Nikfar; Seyedeh Zahra Razavi; Mahdi Sepidarkish; Saman Maroufizadeh; Saeid Safiri; Amir Almasi-Hashiani
Journal:  Syst Rev       Date:  2022-06-19

5.  Tubal ligation, hysterectomy and ovarian cancer: A meta-analysis.

Authors:  Megan S Rice; Megan A Murphy; Shelley S Tworoger
Journal:  J Ovarian Res       Date:  2012-05-15       Impact factor: 4.234

6.  Tubal ligation in relation to menopausal symptoms and breast cancer risk.

Authors:  H B Nichols; D D Baird; L A DeRoo; G E Kissling; D P Sandler
Journal:  Br J Cancer       Date:  2013-08-06       Impact factor: 7.640

7.  Tubal ligation and incidence of 26 site-specific cancers in the Million Women Study.

Authors:  Kezia Gaitskell; Kate Coffey; Jane Green; Kirstin Pirie; Gillian K Reeves; Ahmed A Ahmed; Isobel Barnes; Valerie Beral
Journal:  Br J Cancer       Date:  2016-04-21       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.